# US 2013/0156807 A1 · Conjugates of synthetic tlr agonists and uses therefor

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0156807 A1
- Document ID: US20130156807A1
- Status: Published application
- Kind: A1
- Application number: 13/736,545
- Filed: 2013-01-08
- Published: 2013-06-20
- Earliest claimed: 2007-02-07
- Assignees: The Regents of the University of California
- Inventors: Dennis A. Carson; Howard B. Cottam; Woldgang Wrasidlo; Christina C.N. Wu; Gregory A. Daniels
- Web page: https://patentgrep.com/patent/US20130156807A1

## CPC

- A61K 39/07: Bacillus
- A61K 31/52: Purines, e.g. adenine
- A61K 39/085: Staphylococcus
- A61K 39/39: characterised by the immunostimulating additives, e.g. chemical adjuvants
- A61K 47/6911: {the form being a liposome}
- A61P 11/00: Drugs for disorders of the respiratory system
- A61P 11/06: Antiasthmatics
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 31/04: Antibacterial agents
- A61P 31/12: Antivirals
- A61P 31/22: for herpes viruses
- A61P 35/00: Antineoplastic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 487/04: Ortho-condensed systems
- C07F 9/65616: {containing the ring system [IMAGE cpc-sch-C07F-1006.gif] having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs}
- A61K 2039/55511: {Organic adjuvants}
- A61K 2039/55555: {Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)

## Abstract

The invention provides TLR agonists and conjugates thereof useful in vaccines and to prevent, inhibit or treat a variety of disorders including pathogen infection and asthma.

## Claims

### Claim 1

A method for inducing an immune response in a mammal comprising: administering to a mammal a compound of formula A in an amount effective to induce an immune response in the mammal, the compound of formula A having the structure:
or a pharmaceutically acceptable salt thereof, wherein:
X1 is —O—;
R1 is hydrogen, (C1-C10)alkyl or (C1-C10)alkyl substituted with (C1-C6)alkoxy;
X2 is C(O); and
R3 is dioleoylphosphatidyl ethanolamine (DOPE).

### Claim 2 (depends on 1)

The method of claim 1, wherein R1 of the compound of Formula A is a (C1-C10)alkyl substituted with (C1-C6)alkoxy.

### Claim 3 (depends on 1)

The method of claim 1, wherein R1 of the compound of Formula A is —(CH2)2—OCH3

### Claim 4 (depends on 1)

The method of claim 1, wherein the compound of Formula A is a compound of formula

### Claim 5 (depends on 1)

The method of claim 1, further comprising administering to the mammal an antigen.

### Claim 6 (depends on 5)

The method of claim 5, wherein the antigen is the antigen of a microbe, the antigen of a virus or a cancer antigen.

### Claim 7 (depends on 5)

The method of claim 5, wherein the antigen comprises the antigen of a microbe.

### Claim 8 (depends on 7)

The method of claim 7, wherein the microbe is a bacteria.

### Claim 9 (depends on 8)

The method of claim 8, wherein the bacteria is gram-positive.

### Claim 10 (depends on 9)

The method of claim 9, wherein the gram-positive bacteria is Staphylococcus aureus.

### Claim 11 (depends on 9)

The method of claim 9, wherein the gram-positive bacteria is Bacillus anthracis.

### Claim 12 (depends on 7)

The method of claim 7, wherein the antigen of a microbe is spores of a gram-positive bacterium.
